Center For Neurologic Diseases is categorized under Neurologists in Boston, MA and active since 2010.
Center For Neurologic Diseases was established in 2010, and today employs 1 to 4, earning $20.000.000 to $49.9999.999 per year. This is a Neurologists business, which does work in the B2C market, and is classified as a Neurologists, under code number 6214930 by the NAICS.
If you are seeking more information, feel free to contact Joyce Morin, Manager at the company’s single location by writing to 77 Avenue Louis Pasteur, Boston, Massachusetts MA 02115 or by phoning (617) 525-5300. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Center For Neurologic Diseases |
| Contact Person: | Joyce Morin, Manager |
| Address: | 77 Avenue Louis Pasteur, Boston, Massachusetts 02115 |
| Phone Number: | (617) 525-5300 |
| Annual Revenue (USD): | $20.000.000 to $49.9999.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Neurologists |
| SIC Code: | 8011 |
| NAICS Code: | 6214930 |
| Share This Business: |
Center For Neurologic Diseases was started in 2010 to provide professional Neurologists under the SIC code 8011 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $20.000.000 to $49.9999.999 per annum.
Feel free to contact Joyce Morin, Manager for inquiries that concern Center For Neurologic Diseases by calling the company number (617) 525-5300, as your correspondence is most welcome. Additionally, the physical location of the single location of Center For Neurologic Diseases can be found at the coordinates 42.337812,-71.102781 as well as the street address 77 Avenue Louis Pasteur in Boston, Massachusetts 02115.
For its online presence, you may visit Center For Neurologic Diseases’s website at and engage with its social media outlets through on Twitter and on Facebook.